Status | Study |
Active, not recruiting |
Study Name: Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer Condition: Head and Neck Cancer Date: 2009-02-24 Interventions: Radiation: stereotactic radiosurgery Given in 2 fractionated doses or 5 fractionated doses |
Completed |
Study Name: Family Quality of Life Among Families With a Member Who is a Cancer Patient Condition: Breast Cancer Colorectal Cancer Head and Neck Cancer Date: 2007-10-13 Interventions: Other: questionnaire administration |
Completed |
Study Name: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Condition: Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma A Date: 2007-06-25 Interventions: Drug: bevacizumab Given IV |
Active, not recruiting |
Study Name: Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer Condition: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Basal Cell Carcinoma of the Date: 2007-05-03 Interventions: Drug: HPPH Given IV |
Completed |
Study Name: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Condition: Adenocarcinoma of the Colon Adenocarcinoma of the Rectum A Date: 2006-11-08 Interventions: Drug: cetuximab Given IV |
Terminated |
Study Name: Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer Condition: High-grade Salivary Gland Mucoepidermoid Carcinoma Recurrent Sa Date: 2005-08-02 Interventions: Biological: trastuzumab Given |
Completed |
Study Name: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Adenoi Date: 2005-01-07 Interventions: Drug: erlotinib hydrochloride |
Completed |
Study Name: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Condition: High-grade Salivary Gland Carcinoma High-grade Salivary Gland Mucoepid Date: 2004-11-05 Interventions: Drug: lapatinib ditosylate Giv |
Completed |
Study Name: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Male Breast Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Date: 2004-08-04 Interventions: Drug: alvespimycin hydrochloride |
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition: Anaplastic Thyroid Cancer Insular Thyroid Cancer Metastati Date: 2003-09-10 Interventions: Drug: gefitinib Given orally Other Names: |